Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine whether the addition of cisplatin-based chemotherapy (CT) to pelvic radiation
therapy (RT) will improve the survival of early-stage, high-risk patients with cervical
carcinoma.